StockData
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) stock

LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.78+0.03 (+1.71%)

Close on Nov 17, 2026Market cap $792.02MP/E –Yield –

Lexicon Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Lexicon Pharmaceuticals's gross margin for the twelve months ending Jun 30, 2026 was 99.1%. For fiscal 2025 it was 99.4%, against 98.0% the year before. The highest annual figure on record is 100.0% in fiscal 2015.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202599.4%+1.4
FY2024Dec 31, 202498.0%+5.1
FY2023Dec 31, 202392.9%−7.1
FY2022Dec 31, 2022100.0%+0.0
FY2021Dec 31, 2021100.0%+8.0
FY2020Dec 31, 202092.0%−7.0
FY2019Dec 31, 201999.0%+2.9
FY2018Dec 31, 201896.1%−1.9
FY2017Dec 31, 201797.9%−2.1
FY2016Dec 31, 2016100.0%+0.0
FY2015Dec 31, 2015100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202694.4%−5.5
Q1 FY2026Mar 31, 202699.5%+1.9
Q4 FY2025Dec 31, 202596.3%−2.3
Q3 FY2025Sep 30, 202599.9%+4.0
Q2 FY2025Jun 30, 202599.9%+10.0
Q1 FY2025Mar 31, 202597.6%+0.4
Q4 FY2024Dec 31, 202498.7%+8.7
Q3 FY2024Sep 30, 202495.9%+0.3
Q2 FY2024Jun 30, 202489.9%−7.6
Q1 FY2024Mar 31, 202497.3%−2.7
Q4 FY2023Dec 31, 202390.0%−10.0
Q3 FY2023Sep 30, 202395.7%−4.3
Q2 FY2023Jun 30, 202397.5%−2.5
Q1 FY2023Mar 31, 2023100.0%+0.0
Q4 FY2022Dec 31, 2022100.0%+0.0
Q3 FY2022Sep 30, 2022100.0%+0.0
Q2 FY2022Jun 30, 2022100.0%+0.0
Q4 FY2021Dec 31, 2021100.0%+0.0
Q3 FY2021Sep 30, 2021100.0%+9.5
Q2 FY2021Jun 30, 2021100.0%+7.9
Q1 FY2021Mar 31, 2021100.0%+7.1
Q4 FY2020Dec 31, 2020100.0%+8.9
Q3 FY2020Sep 30, 202090.5%−9.3
Q2 FY2020Jun 30, 202092.1%+5.8
Q1 FY2020Mar 31, 202092.9%−1.1
Q4 FY2019Dec 31, 201991.1%−5.5
Q3 FY2019Sep 30, 201999.8%+7.7
Q2 FY2019Jun 30, 201986.3%−7.6
Q1 FY2019Mar 31, 201994.0%−3.9
Q4 FY2018Dec 31, 201896.7%−1.7
Q3 FY2018Sep 30, 201892.1%−5.7
Q2 FY2018Jun 30, 201893.9%−1.6
Q1 FY2018Mar 31, 201897.9%−0.8
Q4 FY2017Dec 31, 201798.4%−1.6
Q3 FY2017Sep 30, 201797.8%−2.2
Q2 FY2017Jun 30, 201795.6%–
Q1 FY2017Mar 31, 201798.7%–
Q4 FY2016Dec 31, 2016100.0%–
Q3 FY2016Sep 30, 2016100.0%–

More Lexicon Pharmaceuticals figures

See a number that looks wrong?